MERISTEM Therapeutics & SBH Sciences Announce Agreement for Joint Development of Animal-Free Recombinant Proteins
News Nov 29, 2007
MERISTEM Therapeutics and SBH Sciences have entered an agreement to co-develop recombinant proteins produced in genetically engineered tobacco for research and development and diagnostic applications.
The first proteins selected for development are human proteins from the growth factor and hormone families. Through the combined expertise of MERISTEM and SBH the companies will strive to provide a large variety of human proteins to Research and Development organizations.
Meristem's experience and know-how in plant-based stable expression of proteins combined with SBH's customized purification technology will ensure speed up of production and superior quality of proteins. Proteins expressed in Meristem's system are free of pathogens transmissible to humans.
Researchers Discover Mutation That Appears to Protect Against Multiple Aspects of Biological AgingNews
The first genetic mutation that appears to protect against multiple aspects of biological aging in humans has been discovered in an extended family of Old Order Amish living in the vicinity of Berne, Indiana, report Northwestern Medicine scientists.READ MORE
Defects in Cell’s ‘Waste Disposal System’ Linked to Parkinson’sNews
An international study has shed new light on the genetic factors associated with Parkinson’s disease, pointing at a group of lysosomal storage disorder genes as potential major contributors to the onset and progression of this common neurodegenerative disorder.READ MORE
Mouse Model Demonstrates Potential of New Autism DrugNews
Scientists have performed a successful test of a possible new drug in a mouse model of an autism disorder. The candidate drug, largely corrected electrical, behavioral and brain abnormalities in the mice.READ MORE